Table 2
Decreased ratio of BNP and NT-proBNP after tumour resection
| Δ BNP (%)* | P value | Δ NT-proBNP (%)* | P value | |
| Mean±SD | Mean±SD | |||
| Total (n=129) | 38.2±32.8 | 27.9±39.7 | ||
| Karnofsky performance status | ||||
| >80% (n=78) | 34.2±35.4 | 0.0120 | 24.1±43.3 | 0.1262 |
| <80% (n=23) | 51.0±18.0 | 40.0±21.8 | ||
| Grade | ||||
| 1/2 (n=73) | 31.4±35.6 | 0.0030 | 24.7±40.6 | 0.3012 |
| 3/4 (n=56) | 47.6±26.1 | 32.1±38.6 | ||
| pT | ||||
| 1/2 (n=71) | 28.9±38.3 | 0.0031 | 20.7±42.8 | 0.0575 |
| 3/4 (n=58) | 45.8±25.7 | 33.6±36.5 | ||
| Distant metastasis (M) | ||||
| M0 (n=80) | 32.5±37.5 | 0.0076 | 21.8±45.3 | 0.0303 |
| M1 (n=49) | 49.6±15.8 | 40.3±20.5 | ||
| Decreased ratio (Δ)* = |
| ×100 (%) | ||
BNP, brain natriuretic peptide; NT-proBNP, N-terminal pro-BNP.